Off-resonance saturation as an MRI method to quantify ferritin-bound iron in the post-mortem brain
暂无分享,去创建一个
S. V. van Duinen | L. van der Weerd | J. Langendonk | L. Bossoni | I. Hegeman-Kleinn | A. Webb | L. Vroegindeweij | Lydiane Hirschler | L. Hirschler
[1] R. Egli,et al. Effects of Alzheimer’s disease and formalin fixation on the different mineralised-iron forms in the human brain , 2020, Scientific Reports.
[2] Louise van der Weerd,et al. Quantitative MRI and laser ablation-inductively coupled plasma-mass spectrometry imaging of iron in the frontal cortex of healthy controls and Alzheimer’s disease patients , 2020, NeuroImage.
[3] E. Haacke,et al. Intracranial iron distribution and quantification in aceruloplasminemia: A case study. , 2020, Magnetic resonance imaging.
[4] M. Does,et al. Iron, Myelin, and the Brain: Neuroimaging Meets Neurobiology , 2019, Trends in Neurosciences.
[5] Caihong Jiang,et al. Quantifying iron content in magnetic resonance imaging , 2019, NeuroImage.
[6] Siegfried Trattnig,et al. The influence of brain iron and myelin on magnetic susceptibility and effective transverse relaxation - A biochemical and histological validation study , 2018, NeuroImage.
[7] J. Goeman,et al. Quantitative comparison of different iron forms in the temporal cortex of Alzheimer patients and control subjects , 2018, Scientific Reports.
[8] P. So,et al. The Aging of Iron Man , 2018, Front. Aging Neurosci..
[9] B. Stockwell,et al. Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease , 2017, Cell.
[10] L. Elia,et al. Ferritin, cellular iron storage and regulation , 2017, IUBMB life.
[11] M. Conrad,et al. Ferroptosis Inhibition : Mechanisms and [ 280 _ TD $ DIFF ] Opportunities , 2017 .
[12] Yi Wang,et al. The clinical utility of QSM: disease diagnosis, medical management, and surgical planning , 2017, NMR in biomedicine.
[13] Jeff H Duyn,et al. Contributions to magnetic susceptibility of brain tissue , 2017, NMR in biomedicine.
[14] A. F. Gietl,et al. Colocalization of cerebral iron with Amyloid beta in Mild Cognitive Impairment , 2016, Scientific Reports.
[15] Q. Vuong,et al. Improvement of the Off-Resonance Saturation, an MRI sequence for positive contrast with SPM particles: Theoretical and experimental study. , 2016, Journal of magnetic resonance.
[16] H. Reichmann,et al. Role of iron in neurodegenerative diseases , 2016, Journal of Neural Transmission.
[17] N. Raz,et al. Appraising the Role of Iron in Brain Aging and Cognition: Promises and Limitations of MRI Methods , 2015, Neuropsychology Review.
[18] D. Giavarina. Understanding Bland Altman analysis , 2015, Biochemia medica.
[19] Julie C Stout,et al. Iron accumulation in the basal ganglia in Huntington's disease: cross-sectional data from the IMAGE-HD study , 2015, Journal of Neurology, Neurosurgery & Psychiatry.
[20] Q. Vuong,et al. Bottom-up study of the MRI positive contrast created by the Off-Resonance Saturation sequence. , 2015, Journal of magnetic resonance.
[21] Jeff H Duyn,et al. The role of iron in brain ageing and neurodegenerative disorders , 2014, The Lancet Neurology.
[22] P. Arosio,et al. Biology of ferritin in mammals: an update on iron storage, oxidative damage and neurodegeneration , 2014, Archives of Toxicology.
[23] Robert Turner,et al. Myelin and iron concentration in the human brain: A quantitative study of MRI contrast , 2014, NeuroImage.
[24] S. V. van Duinen,et al. Comparison of Histological Techniques to Visualize Iron in Paraffin-embedded Brain Tissue of Patients with Alzheimer’s Disease , 2013, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[25] R. Bowtell,et al. Fiber orientation-dependent white matter contrast in gradient echo MRI , 2012, Proceedings of the National Academy of Sciences.
[26] Ferdinand Schweser,et al. Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study , 2012, NeuroImage.
[27] Olivier Sandre,et al. A Universal Scaling Law to Predict the Efficiency of Magnetic Nanoparticles as MRI T2‐Contrast Agents , 2012, Advanced healthcare materials.
[28] David H Salat,et al. Alterations in brain transition metals in Huntington disease: an evolving and intricate story. , 2012, Archives of neurology.
[29] H. Morita,et al. Extensive brain pathology in a patient with aceruloplasminemia with a prolonged duration of illness. , 2012, Human pathology.
[30] P. Pan,et al. Desferrioxamine treatment of aceruloplasminemia: Long‐term follow‐up , 2011, Movement disorders : official journal of the Movement Disorder Society.
[31] Nirbhay N. Yadav,et al. Chemical exchange saturation transfer (CEST): What is in a name and what isn't? , 2011, Magnetic resonance in medicine.
[32] J. Cristian Salgado,et al. Mathematical modeling of the dynamic storage of iron in ferritin , 2010, BMC Systems Biology.
[33] S. Ropele,et al. Quantitative MR imaging of brain iron: a postmortem validation study. , 2010, Radiology.
[34] R. Roos,et al. MRI T2 Hypointensities in basal ganglia of premanifest Huntington's disease , 2010, PLoS currents.
[35] L. Gutiérrez,et al. Could a dysfunction of ferritin be a determinant factor in the aetiology of some neurodegenerative diseases? , 2010, Biochimica et biophysica acta.
[36] S. Rivera-Mancía,et al. The transition metals copper and iron in neurodegenerative diseases. , 2010, Chemico-biological interactions.
[37] Bejoy Thomas,et al. Principles, techniques, and applications of T2*-based MR imaging and its special applications. , 2009, Radiographics : a review publication of the Radiological Society of North America, Inc.
[38] J. Bulte,et al. Direct saturation MRI: Theory and application to imaging brain iron , 2009, Magnetic resonance in medicine.
[39] M. House,et al. 1.4T study of proton magnetic relaxation rates, iron concentrations, and plaque burden in Alzheimer's disease and control postmortem brain tissue , 2008, Magnetic resonance in medicine.
[40] R. Muller,et al. Relaxation by clustered ferritin: a model for ferritin‐induced relaxation in vivo , 2007, NMR in biomedicine.
[41] Jim Mintz,et al. Myelin Breakdown and Iron Changes in Huntington’s Disease: Pathogenesis and Treatment Implications , 2007, Neurochemical Research.
[42] Xiaoping Hu,et al. Off‐resonance saturation as a means of generating contrast with superparamagnetic nanoparticles , 2006, Magnetic resonance in medicine.
[43] S. David,et al. Age-Related Changes in Iron Homeostasis and Cell Death in the Cerebellum of Ceruloplasmin-Deficient Mice , 2006, The Journal of Neuroscience.
[44] J. Connor,et al. Iron, brain ageing and neurodegenerative disorders , 2004, Nature Reviews Neuroscience.
[45] K. Arima,et al. Astrocytic Deformity and Globular Structures Are Characteristic of the Brains of Patients with Aceruloplasminemia , 2002, Journal of neuropathology and experimental neurology.
[46] A. Tanimoto,et al. Relaxation effects of clustered particles , 2001, Journal of magnetic resonance imaging : JMRI.
[47] Y. Gruenbaum,et al. Repression of ferritin expression increases the labile iron pool, oxidative stress, and short-term growth of human erythroleukemia cells. , 2001, Blood.
[48] G. Bartzokis,et al. Increased basal ganglia iron levels in Huntington disease. , 1999, Archives of neurology.
[49] R A Brooks,et al. Relaxometry and magnetometry of ferritin , 1998, Magnetic resonance in medicine.
[50] A. Berkowitz,et al. MAGNETIC HYSTERESIS ANOMALIES IN FERRITIN , 1997 .
[51] J. Bulte,et al. Comparison of t2 relaxation in blood, brain, and ferritin , 1995, Journal of magnetic resonance imaging : JMRI.
[52] W H Oldendorf,et al. Field dependent transverse relaxation rate increase may be a specific measure of tissue iron stores , 1993, Magnetic resonance in medicine.
[53] C. Morris,et al. Iron and aluminium in relation to brain ferritin in normal individuals and Alzheimer's-disease and chronic renal-dialysis patients. , 1992, The Biochemical journal.
[54] J. Schenck,et al. Health and Physiological Effects of Human Exposure to Whole‐Body Four‐Tesla Magnetic Fields during MRI , 1992, Annals of the New York Academy of Sciences.
[55] Douglas G. Altman,et al. Measurement in Medicine: The Analysis of Method Comparison Studies , 1983 .
[56] B. Hallgren,et al. THE EFFECT OF AGE ON THE NON‐HAEMIN IRON IN THE HUMAN BRAIN , 1958, Journal of neurochemistry.
[57] D. Harman. Aging: a theory based on free radical and radiation chemistry. , 1956, Journal of gerontology.
[58] J. Rogers,et al. Perturbed iron distribution in Alzheimer's disease serum, cerebrospinal fluid, and selected brain regions: a systematic review and meta-analysis. , 2014, Journal of Alzheimer's disease : JAD.
[59] Erika P. Raven,et al. Increased iron levels and decreased tissue integrity in hippocampus of Alzheimer's disease detected in vivo with magnetic resonance imaging. , 2013, Journal of Alzheimer's disease : JAD.
[60] E. Haacke,et al. Imaging iron stores in the brain using magnetic resonance imaging. , 2005, Magnetic resonance imaging.